Clinical Trial Update: Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study update on radioembolization with Yttrium-90 microspheres for intermediate or advanced hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Yttrium-90 microspheres (yttrium-90 microspheres)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Hepatocellular Carcinoma, Liver Cancer | Phase 2 | Status: COMPLETED